TRS85 inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of TRS85, a component of the TRAPP (Transport Protein Particle) complex, which is involved in intracellular trafficking processes. The TRAPP complex functions as a guanine nucleotide exchange factor (GEF) that activates Rab GTPases, essential regulators of vesicular transport between various cellular compartments, such as the endoplasmic reticulum, Golgi apparatus, and endosomes. TRS85 is a key subunit of the TRAPP complex that contributes to its role in vesicle tethering and fusion, playing an important role in processes like autophagy and the regulation of membrane trafficking. Inhibiting TRS85 disrupts the assembly or function of the TRAPP complex, leading to changes in intracellular vesicle transport and the movement of proteins and other cargo within the cell.
The chemical design of TRS85 inhibitors typically focuses on blocking the specific interactions between TRS85 and other components of the TRAPP complex or interfering with its ability to bind and activate Rab GTPases. These inhibitors may be small molecules that fit into the active or binding sites of TRS85, preventing its participation in vesicle tethering and membrane fusion events. Structural studies of TRS85 provide insights into its unique molecular features, allowing for the development of inhibitors that achieve high specificity. By inhibiting TRS85, researchers aim to understand its exact role in vesicle transport pathways, autophagy, and the maintenance of intracellular trafficking networks. Studying TRS85 inhibitors helps to elucidate the complex regulation of cellular transport systems and how specific protein interactions within the TRAPP complex control the dynamics of membrane traffic and organelle function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine interferes with lysosomes in the cell, potentially leading to reduced autophagy and indirectly affecting TRAPPC8 expression. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts ER-Golgi transport by inhibiting the formation of COPI and COPII vesicles, which could lower TRAPPC8 levels. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, causing ER stress and possibly downregulating TRAPPC8 as part of the unfolded protein response. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to disrupt protein trafficking by modulating vesicle formation, potentially decreasing TRAPPC8 expression. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin, a sodium ionophore, disrupts Golgi function, which may lead to a reduction in TRAPPC8 expression. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic acid induces ER stress and can trigger an unfolded protein response, potentially decreasing TRAPPC8 levels. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $176.00 $624.00 | 3 | |
Cyclopiazonic acid inhibits calcium pumps, causing calcium imbalance and ER stress that could lower TRAPPC8 expression. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin causes ER stress by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), possibly reducing TRAPPC8. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 inhibits the proteasome, leading to protein accumulation and ER stress, which may downregulate TRAPPC8 expression. | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $34.00 $104.00 | 87 | |
Salubrinal selectively inhibits phosphatase targeting eIF2α, inducing ER stress and potentially diminishing TRAPPC8 expression. | ||||||